Laurel Habel to Carcinoma, Ductal, Breast
This is a "connection" page, showing publications Laurel Habel has written about Carcinoma, Ductal, Breast.
Connection Strength
1.937
-
Re: Cancer Outcomes in DCIS Patients Without Locoregional Treatment. J Natl Cancer Inst. 2020 02 01; 112(2):214-215.
Score: 0.677
-
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85.
Score: 0.334
-
Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 1998 Aug; 7(8):689-96.
Score: 0.153
-
Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg. 1997 Jan; 225(1):69-75.
Score: 0.137
-
Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.122
-
Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system. J Clin Oncol. 2014 Jul 10; 32(20):2151-8.
Score: 0.114
-
Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2014 Nov; 21(12):3766-73.
Score: 0.114
-
Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2013 Mar; 22(3):365-73.
Score: 0.104
-
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
Score: 0.103
-
Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 Jul 01; 27(19):3211-6.
Score: 0.081